Genpact Ltd is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown modest financial growth and positive momentum in its Advanced Technology Solutions segment, the bearish moving averages, lack of strong trading signals, and hedge fund selling trends suggest caution. The stock is better suited for monitoring rather than immediate investment.
The MACD is positive and expanding, indicating a mild bullish momentum. However, the RSI is neutral at 54.095, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 37.946 and 39.008, while support levels are at 34.508 and 33.446.

The company posted solid Q4 results, with revenue up 5.65% YoY and EPS up 3.80% YoY. Advanced Technology Solutions segment continues to show strong momentum.
Hedge funds are significantly selling the stock, with an 805.73% increase in selling over the last quarter. Analysts have lowered price targets, and the stock lacks strong trading signals from AI Stock Picker or SwingMax.
In Q4 2025, revenue increased by 5.65% YoY to $1.319 billion, net income rose by 0.83% YoY to $143.09 million, and EPS increased by 3.80% YoY to $0.82. Gross margin improved by 2.33% YoY to 36%.
Needham maintains a Buy rating but lowered the price target to $50 from $53, citing solid Q4 results driven by Advanced Technology Solutions. Susquehanna lowered the price target to $42 from $50, maintaining a Neutral rating due to concerns about slower core business growth despite ATS momentum.